期刊文献+

白血病相关基因zo-1参与白血病发病过程及其机制的初步研究 被引量:1

Preliminary Study on Leukemia Related Gene zo-1 Involved in Pathogenesis of Leukemia
下载PDF
导出
摘要 本研究探讨新的白血病相关基因zo-1在白血病细胞中的作用及其初步机制。应用甲基化PCR方法验证THP-1等白血病细胞中基因zo-1甲基化与白血病的关系,用甲基化PCR及RT-PCR方法验证THP-1等白血病细胞系中基因zo-1甲基化与基因表达的关系。选择基因zo-1高表达的THP-1细胞,用脂质体Oligofectamine将针对基因zo-1的小干扰RNA转染THP-1细胞,RT-PCR方法验证抑制效率,AnnexinV和PI观察细胞凋亡率,PI检测细胞周期,CCK-8检测细胞增殖。结果表明:急性白血病人中基因zo-1呈高甲基化状态,健康人群中基因zo-1不发生甲基化。基因zo-1未甲基化的THP-1细胞系高表达基因zo-1;基因zo-1高甲基化的Molt4及HL-60细胞系中不表达基因zo-1。脂质体Oligofectamine转染针对zo-1的小干扰RNA成功地抑制了THP-1细胞基因zo-1的表达,而不影响THP-1细胞增殖、细胞周期及细胞凋亡。结论:基因zo-1为白血病相关基因,急性白血病中基因zo-1高甲基化,基因zo-1的甲基化状态调控基因zo-1表达。THP-1细胞中基因zo-1表达缺失不影响细胞增殖、细胞周期及细胞凋亡。 The study was aimed to identify a new leukemia related gene zo-1 from leukemia and to explore its mechanism in leukemia. Methylation specific PCR(MSP) was used for testing gene zo-1 methylation in leukemia cells. The gene zo-1 specific siRNA was designed according to its sequence, and transfected into THP-1 cell, and the cells were cultured for 48 hours before harvesting. The effect of zo-1 siRNA was monitored by RT-PCR. The cellular proliferation activity was assayed by CCK-8, the apoptosis was detected by Annexin-V- fl isothiocyanate (FITC) assay, and cell cycle was observed by propidium iodide (PI). The results indicated that the gene zo-1 in patients with acute leukemia was hypermethylated, while the gene zo-1 in healthy persons was unmethylated. The THP-1 cells with unmethylation of zo-1 gene promoter overexpressed the gene zo-1, while the Molt4 and HL-60 cells with hypermethylation of gene zo-1 promoter did not express the gene zo-1. The silenced zo-1 gene in Molt4 and HL-60 leukemia cell lines could be reactivated by demethylation treatment with 5-AZA-dC. The oligofectamine-transfected siRNA for zo-1 gene successfully inhibited the expression of gene zo-1 in THP-I cells, but did not interfere with cell proliferation, cell cycle and apoptosis. It is concluded that gene zo-1 is a leukemia-related gene. Gene zo-1 in acute leukemia was hypermethylated, the methylation status of gene zo-1 regulates the expression of gene zo-l. Lack of gene zo-1 expression in THP-1 cells does not infuence the cell proliferation, apoptosis and cell cycle, which suggests that the methylation of gene zo-1 may be involved in the genesis of acute leukemia, its mechanism is worthy to be studied.
出处 《中国实验血液学杂志》 CAS CSCD 2009年第5期1140-1143,共4页 Journal of Experimental Hematology
基金 国家基础研究973项目(编号2005CB522400) 国家自然科学基金(编号30572108)
关键词 白血病 ZO-1基因 甲基化 leukemia zo-1 gene methylation
  • 相关文献

参考文献1

二级参考文献1

同被引文献73

  • 1Dellett M, O'Hagan KA, Colyer HA, Mills KI. Identification of gene networks associated with acute myeloid leukemia by comparative molecular methylation and expression profiling. Biomark Cancer 2010; 2: 43-55.
  • 2Singh R, Cadeddu RP, Frobel J, Wilk CM, Bruns I, Zerbini LF, et al. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway. Apoptosis 2011; 16(9): 889-901.
  • 3Khasawneh MK, Abdel-Wahab O. Recent discoveries in molecular characterization of acute myeloid leukemia. Curr Hematol Malig Rep 2014; 9(2): 93-9.
  • 4Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013, CA Cancer J Clin 2013; 63(1): 11-30.
  • 5常乃柏.急性髓系白血病DNA甲基化及治疗进展.中华临床医师杂志2013;12:5504-6.
  • 6Kozu T, Fukuyama T, Yamami T, Akagi K ,Kaneko Y. MYND- less splice variants of AML 1-MTG8 (RUNX 1-CBFA2T 1) areexpressed in leukemia with t(8;21). Genes Chromosomes Cancer 2005; 43(1): 45-53.
  • 7Wang Q, Sun R, Wu L, Huang J, Wang P, Yuan H, et al. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling, hat J Biochem Cell Bio12013; 45(12): 2852-63.
  • 8Sorrell A, Espenschied C, Wang W, Weitzel J, Chu S, Parker P, et al. Hereditary leukemia due to rare RUNXlc splice variant (L472X) presents with eczematous phenotype. Int J Clin Med 2012; 3(7): doi: 10.4236/ijcm.2012.37110.
  • 9Schnittger S, Kohl TM, Haferlach T, Kern W, Hiddemann W, Spiekermann K, et al. KIT-D816 mutations in AML1-ETO- positive AML are associated with impaired event-free and overall survival. Blood 2006; 107(5): 1791-9.
  • 10Gonzalez M, Barragan E, Bolufer P, Chillon C, Colomer D, Borstein R, et al. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: A study of the PETHEMA group. Br J Haemato12001; 114(1): 99-103.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部